Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448694 · ClinicalTrials.gov registry record
Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss
A clinical trial of Hemorrhage, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT01448694 is a study of Hemorrhage that has completed, run by University of Colorado, Denver. The registered enrollment target is 320 participants, above the 251-participant average among 20 other Hemorrhage trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01448694, a study of Hemorrhage, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is part of a Phase II STTR project to develop an algorithm called CipherSensor to apply feature extraction and machine learning techniques to non-invasive hemodynamic data to identify early signs of acute blood loss. The availability of this information may help to establish required interventions for treating trauma patients and battlefield casualties. Study hypothesis: Hemodynamic changes measured non-invasively during the blood donation process can be modeled to provide early estimations of blood loss.
Conditions Studied
Interventions
- OTHER No treatment
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01448694
The ClinicalTrials.gov registry entry for NCT01448694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 20 other Hemorrhage trials with a reported enrollment target (27% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which No treatment is the first listed.
NCT01448694 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01448694 about?
NCT01448694 is a clinical study titled "Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss". This study is part of a Phase II STTR project to develop an algorithm called CipherSensor to apply feature extraction and machine learning techniques to non-invasive hemodynamic data to identify early signs of acute blood loss. The availability of this information may help to establish required inte...
What is the current status of trial NCT01448694?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2011-11. Estimated completion is 2014-09.
What conditions does trial NCT01448694 study?
This clinical trial studies the following conditions: Hemorrhage.
What interventions are being tested in trial NCT01448694?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT01448694?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01448694 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
RECRUITING · Phase 2
-
NIRS Monitoring in Premature Infants
RECRUITING
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
RECRUITING · Phase 4
-
The Effect of Fluids on Aortic VTI During C-section
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.